Author： Hantouche Christine M. Bitar Khalil M. Nemer Georges M. Obeid Mounir Y. Kadi Lina N. Der-Boghossian Asdghig H. Bikhazi Anwar B.
Publisher： NRC Research Press
ISSN： 1205-7541
Source： Canadian Journal of Physiology and Pharmacology, Vol.88, Iss.1, 2010-01, pp. : 54-63
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. :
Access to resources
Recommend
Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents
Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. :
Cardiovascular Effects of Glucagon-Like Peptide 1
Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. :
By Ribel U. Larsen M.O. Rolin B. Carr R.D. Wilken M. Sturis J. Westergaard L. Deacon C.F. Knudsen L.B.
European Journal of Pharmacology, Vol. 451, Iss. 2, 2002-09 ,pp. :